Zantac / Ranitidine (NDMA Cancer) Lawsuit in Nevada

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Nevada imposes a 3-year statute of limitations for product liability claims (NRS § 11.190(3)(c)) with the discovery rule applicable to latent pharmaceutical injuries. Nevada courts apply Daubert reliability standards for expert testimony. Nevada's 3-year SOL provides a broader filing window than many states for Zantac claimants.

3 years from date of cancer diagnosis discovery (Daubert expert standard)

Nevada Data

Exposure in Nevada

Source: U.S. Census Bureau 2024

Source: NRS § 11.190(3)(c)

Medical Resources

Clinics & Specialists in Nevada

Nevada Cancer Center (Comprehensive Cancer Centers of Nevada)

Renown Regional Medical Center Cancer Center

Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview